Unity Biotechnology CEO Keith Leonard's 2019 pay rises 20% to $3.3M
Unity Biotechnology reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
Unity Biotechnology reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, four executives at Unity Biotechnology received on average a compensation package of $2M, a 9% increase compared to previous year.
Average pay of disclosed executives at Unity Biotechnology
Keith R. Leonard Jr, Chief Executive Officer, received $3.3M in total, which increased by 20% compared to 2018. 58% of Leonard's compensation, or $1.9M, was in option awards. Leonard also received $306K in non-equity incentive plan, $550K in salary, $360K in stock awards, as well as $155K in other compensation.
Robert C. Goeltz II, Chief Financial Officer, received a compensation package of $1.6M, which increased by 79% compared to previous year. 53% of the compensation package, or $854K, was in option awards.
Nathaniel E. David, President, earned $1.6M in 2019, a 44% decrease compared to previous year.
Jamie Dananberg, Chief Medical Officer, received $1.6M in 2019, which increases by 67% compared to 2018.
Related executives
You may also like
Source: SEC filing on April 24, 2020.